Vimarsana
Biggest News Aggregation in the World

Published Online First News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Published Online First. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Published Online First Today - Breaking & Trending Today

HOYA Vision Care Releases Results of First of its Kind Six-Year MiYOSMART Spectacle Lens Follow-up Clinical Study - Vimarsana News

HOYA Vision Care Releases Results of First of its Kind Six-Year MiYOSMART Spectacle Lens Follow-up Clinical Study

/PRNewswire/ -- HOYA Vision Care, a leader in optical technology innovation, shared the results of a six-year follow-up clinical study on its award winning...

The Impact of Regression to the Mean in Psychiatric Drug Studies - Vimarsana News

The Impact of Regression to the Mean in Psychiatric Drug Studies

Could the statistical phenomenon of regression to the mean be responsible for the dramatic effects of placebo in psychiatric drug studies?

Review Finds FDA Approval of Digital Antipsychotic Misguided - Vimarsana News

Review Finds FDA Approval of Digital Antipsychotic Misguided

The approval of the digital antipsychotic may open the door for more pharmaceutical company profits without evidence of benefits to patients.

HOYA Vision Care Releases Results of Three-Year MiYOSMART Spectacle Lens Follow-up Study - Vimarsana News

HOYA Vision Care Releases Results of Three-Year MiYOSMART Spectacle Lens Follow-up Study

Share this article Share this article BANGKOK, April 27, 2021 /PRNewswire/ -- HOYA Vision Care, a leader in optical technology innovation, shared the results of a three-year follow-up clinical study on its award winning MiYOSMART spectacle lens with patented Defocus Incorporated Multiple Segments (D.I.M.S.) Technology after releasing the information at the recent European Academy of Optometry and Optics (EAOO) '21 conference. The new study, published in March 2021 in the British Journal of Ophthalmology, was conducted by the Centre for Myopia Research at The Hong Kong Polytechnic University...

Dr. Daniel Kopans: Will the USPSTF heed science on breast screening? - Vimarsana News

Dr. Daniel Kopans: Will the USPSTF heed science on breast screening?

Dr. Daniel Kopans. The history of the U.S. Preventive Services Task Force (USPSTF) on breast screening is another case in point, in which decisions on mammography guidelines have been based on flawed analyses of scientific data. When the USPSTF last week opened a new review of breast screening guidelines, it created the opportunity to revisit the group's flawed decision in 2009 to not recommend breast screening for women in their 40s. However, a number of factors need to be addressed for the 2021 review to present a fair and impartial review of the science and evidence in favor of breast sc...